Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Vaccines

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 254 articles:
HTML format



Single Articles


    November 2021
  1. MURPHY WJ, Longo DL
    A Possible Role for Anti-idiotype Antibodies in SARS-CoV-2 Infection and Vaccination.
    N Engl J Med. 2021 Nov 24. doi: 10.1056/NEJMcibr2113694.
    PubMed    


  2. RUBIN EJ, Baden LR, Grinsztejn B, Morrissey S, et al
    Audio Interview: Covid-19 in Brazil and New Evidence for Vaccinating Younger Children.
    N Engl J Med. 2021;385:e79.
    PubMed    


  3. LOPEZ BERNAL J, Gower C, Andrews N
    Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant. Reply.
    N Engl J Med. 2021 Nov 10. pii: 10.1056/NEJMc2113090.
    PubMed    


  4. EMANI VR, Reddy R, Goswami S
    Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant.
    N Engl J Med. 2021 Nov 10. pii: 10.1056/NEJMc2113090.
    PubMed    


  5. LINSENMEYER K, Gupta K, Charness ME
    Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant.
    N Engl J Med. 2021 Nov 10. pii: 10.1056/NEJMc2113090.
    PubMed    


  6. TORGOVNICK J
    Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant.
    N Engl J Med. 2021 Nov 10. pii: 10.1056/NEJMc2113090.
    PubMed    


  7. WALTER EB, Talaat KR, Sabharwal C, Gurtman A, et al
    Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age.
    N Engl J Med. 2021 Nov 9. doi: 10.1056/NEJMoa2116298.
    PubMed     Abstract available


  8. MONTO AS
    The Future of SARS-CoV-2 Vaccination - Lessons from Influenza.
    N Engl J Med. 2021 Nov 6. doi: 10.1056/NEJMp2113403.
    PubMed    


  9. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Do We Have the Tools to End the Covid-19 Pandemic?
    N Engl J Med. 2021;385:e78.
    PubMed    


  10. SCHONBORN L, Thiele T, Kaderali L, Greinacher A, et al
    Decline in Pathogenic Antibodies over Time in VITT.
    N Engl J Med. 2021;385:1815-1816.
    PubMed    


  11. SCULLY M
    VITT after ChAdOx1 nCoV-19 Vaccination. Reply.
    N Engl J Med. 2021 Nov 3. pii: 10.1056/NEJMc2111026.
    PubMed    


  12. GREINACHER A, Schonborn L, Thiele T
    VITT after ChAdOx1 nCoV-19 Vaccination. Reply.
    N Engl J Med. 2021 Nov 3. pii: 10.1056/NEJMc2111026.
    PubMed    


  13. WEBER C, von Hundelshausen P, Siess W
    VITT after ChAdOx1 nCoV-19 Vaccination.
    N Engl J Med. 2021 Nov 3. pii: 10.1056/NEJMc2111026.
    PubMed    


  14. SANTIN AD
    VITT after ChAdOx1 nCoV-19 Vaccination.
    N Engl J Med. 2021 Nov 3. pii: 10.1056/NEJMc2111026.
    PubMed    


  15. URIU K, Kimura I, Shirakawa K, Takaori-Kondo A, et al
    Neutralization of the SARS-CoV-2 Mu Variant by Convalescent and Vaccine Serum.
    N Engl J Med. 2021 Nov 3. doi: 10.1056/NEJMc2114706.
    PubMed    


    October 2021
  16. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: A New Monoclonal Antibody for Covid-19 and Potential Vaccination for Children.
    N Engl J Med. 2021;385:e74.
    PubMed    


  17. ASKENASE PW
    Rare Skin Reactions after mRNA Vaccination, Similar to Jones-Mote Basophil Responses.
    N Engl J Med. 2021;385:1720-1721.
    PubMed    


  18. GOLDBERG Y, Mandel M, Bar-On YM, Bodenheimer O, et al
    Waning Immunity after the BNT162b2 Vaccine in Israel.
    N Engl J Med. 2021 Oct 27. doi: 10.1056/NEJMoa2114228.
    PubMed     Abstract available


  19. DAGAN N, Barda N, Balicer RD
    Adverse Effects after BNT162b2 Vaccine and SARS-CoV-2 Infection, According to Age and Sex.
    N Engl J Med. 2021 Oct 27. doi: 10.1056/NEJMc2115045.
    PubMed    


  20. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: A New Look at Covid-19 Vaccine Boosters.
    N Engl J Med. 2021;385:e72.
    PubMed    


  21. MAGNUS MC, Gjessing HK, Eide HN, Wilcox AJ, et al
    Covid-19 Vaccination during Pregnancy and First-Trimester Miscarriage.
    N Engl J Med. 2021 Oct 20. doi: 10.1056/NEJMc2114466.
    PubMed    


  22. CHIN ET, Leidner D, Zhang Y, Long E, et al
    Effectiveness of the mRNA-1273 Vaccine during a SARS-CoV-2 Delta Outbreak in a Prison.
    N Engl J Med. 2021 Oct 20. doi: 10.1056/NEJMc2114089.
    PubMed    


  23. SHEIKH A, Robertson C, Taylor B
    BNT162b2 and ChAdOx1 nCoV-19 Vaccine Effectiveness against Death from the Delta Variant.
    N Engl J Med. 2021 Oct 20. doi: 10.1056/NEJMc2113864.
    PubMed    


  24. REIS BY, Barda N, Leshchinsky M, Kepten E, et al
    Effectiveness of BNT162b2 Vaccine against Delta Variant in Adolescents.
    N Engl J Med. 2021 Oct 20. doi: 10.1056/NEJMc2114290.
    PubMed    


  25. COLLIER AY, Yu J, McMahan K, Liu J, et al
    Differential Kinetics of Immune Responses Elicited by Covid-19 Vaccines.
    N Engl J Med. 2021 Oct 15. doi: 10.1056/NEJMc2115596.
    PubMed    


  26. NOLAN T, Fortanier AC, Leav B, Poder A, et al
    Efficacy of a Cell-Culture-Derived Quadrivalent Influenza Vaccine in Children.
    N Engl J Med. 2021;385:1485-1495.
    PubMed     Abstract available


  27. RUBIN EJ, Baden LR, Wu KJ, Morrissey S, et al
    Audio Interview: Reporting on Covid-19.
    N Engl J Med. 2021;385:e66.
    PubMed    


  28. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Are Covid-19 Vaccine Boosters Necessary?
    N Engl J Med. 2021;385:e63.
    PubMed    


  29. WITBERG G, Barda N, Hoss S, Richter I, et al
    Myocarditis after Covid-19 Vaccination in a Large Health Care Organization.
    N Engl J Med. 2021 Oct 6. doi: 10.1056/NEJMoa2110737.
    PubMed     Abstract available


  30. MEVORACH D, Anis E, Cedar N, Bromberg M, et al
    Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel.
    N Engl J Med. 2021 Oct 6. doi: 10.1056/NEJMoa2109730.
    PubMed     Abstract available


  31. CHEMAITELLY H, Tang P, Hasan MR, AlMukdad S, et al
    Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar.
    N Engl J Med. 2021 Oct 6. doi: 10.1056/NEJMoa2114114.
    PubMed     Abstract available


  32. LEVIN EG, Lustig Y, Cohen C, Fluss R, et al
    Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months.
    N Engl J Med. 2021 Oct 6. doi: 10.1056/NEJMoa2114583.
    PubMed     Abstract available


  33. THOMPSON MG, Grant L, Meece J
    Prevention of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines. Reply.
    N Engl J Med. 2021 Oct 6. pii: 10.1056/NEJMc2113575.
    PubMed    


  34. ZHANG C, Yin G
    Prevention of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.
    N Engl J Med. 2021 Oct 6. pii: 10.1056/NEJMc2113575.
    PubMed    


  35. SCHOOLEY RT
    Prevention of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.
    N Engl J Med. 2021 Oct 6. pii: 10.1056/NEJMc2113575.
    PubMed    


  36. SANTACATTERINA M, Sanders JW, Weintraub WS
    Prevention of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.
    N Engl J Med. 2021 Oct 6. pii: 10.1056/NEJMc2113575.
    PubMed    


    September 2021
  37. RUBIN EJ, Baden LR, Tofel R, Morrissey S, et al
    Audio Interview: Covid-19 and the Media.
    N Engl J Med. 2021;385:e59.
    PubMed    


  38. FALSEY AR, Sobieszczyk ME, Hirsch I, Sproule S, et al
    Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine.
    N Engl J Med. 2021 Sep 29. doi: 10.1056/NEJMoa2105290.
    PubMed     Abstract available


  39. AMIT S, Gonen T, Regev-Yochay G
    Covid-19 Breakthrough Infections in Vaccinated Health Care Workers. Reply.
    N Engl J Med. 2021;385.
    PubMed    


  40. JUNG J, Sung H, Kim SH
    Covid-19 Breakthrough Infections in Vaccinated Health Care Workers.
    N Engl J Med. 2021;385.
    PubMed    


  41. STUART LM
    In Gratitude for mRNA Vaccines.
    N Engl J Med. 2021 Sep 24. doi: 10.1056/NEJMcibr2111445.
    PubMed    


  42. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Vaccine Efficacy and Boosters in Covid-19.
    N Engl J Med. 2021;385:e54.
    PubMed    


  43. STOKKE JL, Szymanski LJ, Bankamp B, Pratt F, et al
    MMR Vaccine-Associated Disseminated Measles in an Immunocompromised Adolescent.
    N Engl J Med. 2021;385:1246-1248.
    PubMed    


  44. LIANG TJ, Feld JJ, Cox AL, Rice CM, et al
    Controlled Human Infection Model - Fast Track to HCV Vaccine?
    N Engl J Med. 2021;385:1235-1240.
    PubMed    


  45. EL SAHLY HM, Baden LR, Essink B, Doblecki-Lewis S, et al
    Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase.
    N Engl J Med. 2021 Sep 22. doi: 10.1056/NEJMoa2113017.
    PubMed     Abstract available


  46. PILISHVILI T, Gierke R, Fleming-Dutra KE, Farrar JL, et al
    Effectiveness of mRNA Covid-19 Vaccine among U.S. Health Care Personnel.
    N Engl J Med. 2021 Sep 22. doi: 10.1056/NEJMoa2106599.
    PubMed     Abstract available


  47. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: New Evidence on SARS-CoV-2 Vaccine Boosters.
    N Engl J Med. 2021;385:e48.
    PubMed    


  48. TEBAS P, Roberts CC, Muthumani K, Reuschel EL, et al
    Safety and Immunogenicity of an Anti-Zika Virus DNA Vaccine.
    N Engl J Med. 2021;385:e35.
    PubMed     Abstract available


  49. PATEL PD, Patel P, Liang Y, Meiring JE, et al
    Safety and Efficacy of a Typhoid Conjugate Vaccine in Malawian Children.
    N Engl J Med. 2021;385:1104-1115.
    PubMed     Abstract available


  50. FRENCK RW JR, Dormitzer PR, Gurtman A
    BNT162b2 Covid-19 Vaccine in Adolescents. Reply.
    N Engl J Med. 2021;385.
    PubMed    


  51. LIN CH
    BNT162b2 Covid-19 Vaccine in Adolescents.
    N Engl J Med. 2021;385.
    PubMed    


  52. SALIH F, Schonborn L, Kohler S, Franke C, et al
    Vaccine-Induced Thrombocytopenia with Severe Headache.
    N Engl J Med. 2021 Sep 15. doi: 10.1056/NEJMc2112974.
    PubMed    


  53. JARA A, Undurraga EA, Araos R
    Effectiveness of an Inactivated SARS-CoV-2 Vaccine. Reply.
    N Engl J Med. 2021;385.
    PubMed    


  54. ONISHI FJ, Goto JM
    Effectiveness of an Inactivated SARS-CoV-2 Vaccine.
    N Engl J Med. 2021;385.
    PubMed    


  55. CHI H, Chiu NC, Lin CY
    Effectiveness of an Inactivated SARS-CoV-2 Vaccine.
    N Engl J Med. 2021;385.
    PubMed    


  56. OKHOTIN A
    Effectiveness of an Inactivated SARS-CoV-2 Vaccine.
    N Engl J Med. 2021;385.
    PubMed    


  57. THOMAS SJ, Moreira ED Jr, Kitchin N, Absalon J, et al
    Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months.
    N Engl J Med. 2021 Sep 15. doi: 10.1056/NEJMoa2110345.
    PubMed     Abstract available


  58. FALSEY AR, Frenck RW Jr, Walsh EE, Kitchin N, et al
    SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3.
    N Engl J Med. 2021 Sep 15. doi: 10.1056/NEJMc2113468.
    PubMed    


  59. BAR-ON YM, Goldberg Y, Mandel M, Bodenheimer O, et al
    Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel.
    N Engl J Med. 2021 Sep 15. doi: 10.1056/NEJMoa2114255.
    PubMed     Abstract available


  60. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Protecting against Severe Disease and Transmission.
    N Engl J Med. 2021;385:e44.
    PubMed    


  61. SHAH ASV, Gribben C, Bishop J, Hanlon P, et al
    Effect of Vaccination on Transmission of SARS-CoV-2.
    N Engl J Med. 2021 Sep 8. doi: 10.1056/NEJMc2106757.
    PubMed    


  62. MEANEY-DELMAN DM, Ellington SR, Shimabukuro TT
    On Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons. Reply.
    N Engl J Med. 2021 Sep 8. pii: 10.1056/NEJMc2113516.
    PubMed    


  63. SUN H
    On Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons.
    N Engl J Med. 2021 Sep 8. pii: 10.1056/NEJMc2113516.
    PubMed    


  64. ZAUCHE LH, Wallace B, Smoots AN, Olson CK, et al
    Receipt of mRNA Covid-19 Vaccines and Risk of Spontaneous Abortion.
    N Engl J Med. 2021 Sep 8. doi: 10.1056/NEJMc2113891.
    PubMed    


  65. DEAN NE, Hogan JW, Schnitzer ME
    Covid-19 Vaccine Effectiveness and the Test-Negative Design.
    N Engl J Med. 2021 Sep 8. doi: 10.1056/NEJMe2113151.
    PubMed    


  66. THOMPSON MG, Stenehjem E, Grannis S, Ball SW, et al
    Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings.
    N Engl J Med. 2021 Sep 8. doi: 10.1056/NEJMoa2110362.
    PubMed     Abstract available



  67. mRNA Covid-19 Vaccines in Pregnant Women.
    N Engl J Med. 2021 Sep 8. doi: 10.1056/NEJMx210017.
    PubMed    



  68. Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons.
    N Engl J Med. 2021 Sep 8. doi: 10.1056/NEJMx210016.
    PubMed    


  69. WILDER-SMITH A, Mulholland K
    Effectiveness of an Inactivated SARS-CoV-2 Vaccine.
    N Engl J Med. 2021;385:946-948.
    PubMed    


  70. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: A New Round of Rising Covid-19 Numbers.
    N Engl J Med. 2021;385:e41.
    PubMed    


  71. KEEHNER J, Horton LE, Binkin NJ, Laurent LC, et al
    Resurgence of SARS-CoV-2 Infection in a Highly Vaccinated Health System Workforce.
    N Engl J Med. 2021 Sep 1. doi: 10.1056/NEJMc2112981.
    PubMed    


    August 2021
  72. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Assessing Vaccine Safety.
    N Engl J Med. 2021;385:e37.
    PubMed    


  73. UZUN G, Althaus K, Bakchoul T
    No Correlation between Anti-PF4 and Anti-SARS-CoV-2 Antibodies after ChAdOx1 nCoV-19 Vaccination.
    N Engl J Med. 2021 Aug 25. doi: 10.1056/NEJMc2111305.
    PubMed    


  74. BARDA N, Dagan N, Ben-Shlomo Y, Kepten E, et al
    Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting.
    N Engl J Med. 2021 Aug 25. doi: 10.1056/NEJMoa2110475.
    PubMed     Abstract available


  75. CHANDRAMOHAN D, Zongo I, Sagara I, Cairns M, et al
    Seasonal Malaria Vaccination with or without Seasonal Malaria Chemoprevention.
    N Engl J Med. 2021 Aug 25. doi: 10.1056/NEJMoa2026330.
    PubMed     Abstract available


  76. LEE GM
    The Importance of Context in Covid-19 Vaccine Safety.
    N Engl J Med. 2021 Aug 25. doi: 10.1056/NEJMe2112543.
    PubMed    


  77. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Aspects of Covid-19 Immunity.
    N Engl J Med. 2021;385:e31.
    PubMed    


  78. VERMA AK, Lavine KJ, Lin CY
    Myocarditis after Covid-19 mRNA Vaccination.
    N Engl J Med. 2021 Aug 18. doi: 10.1056/NEJMc2109975.
    PubMed    


  79. LANGE B, Gerigk M, Tenenbaum T
    Breakthrough Infections in BNT162b2-Vaccinated Health Care Workers.
    N Engl J Med. 2021 Aug 18. doi: 10.1056/NEJMc2108076.
    PubMed    


  80. TAN CW, Chia WN, Young BE, Zhu F, et al
    Pan-Sarbecovirus Neutralizing Antibodies in BNT162b2-Immunized SARS-CoV-1 Survivors.
    N Engl J Med. 2021 Aug 18. doi: 10.1056/NEJMoa2108453.
    PubMed     Abstract available


  81. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Monoclonal Antibodies and Booster Shots.
    N Engl J Med. 2021;385:e29.
    PubMed    


  82. HALL VG, Ferreira VH, Ku T, Ierullo M, et al
    Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients.
    N Engl J Med. 2021 Aug 11. doi: 10.1056/NEJMc2111462.
    PubMed    


  83. ALI K, Berman G, Zhou H, Deng W, et al
    Evaluation of mRNA-1273 SARS-CoV-2 Vaccine in Adolescents.
    N Engl J Med. 2021 Aug 11. doi: 10.1056/NEJMoa2109522.
    PubMed     Abstract available


  84. PAVORD S, Scully M, Hunt BJ, Lester W, et al
    Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis.
    N Engl J Med. 2021 Aug 11. doi: 10.1056/NEJMoa2109908.
    PubMed     Abstract available


  85. WILLIAMS WW, Ingelfinger JR
    Third Time's a Charm - Covid-19 Vaccine Hope for Solid-Organ Transplant Recipients.
    N Engl J Med. 2021 Aug 11. doi: 10.1056/NEJMe2112866.
    PubMed    


  86. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Looking Back and Looking Forward - Part 2.
    N Engl J Med. 2021;385:e25.
    PubMed    


    July 2021
  87. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Looking Back and Looking Forward - Part 1.
    N Engl J Med. 2021;385:e24.
    PubMed    


  88. BERGWERK M, Gonen T, Lustig Y, Amit S, et al
    Covid-19 Breakthrough Infections in Vaccinated Health Care Workers.
    N Engl J Med. 2021 Jul 28. doi: 10.1056/NEJMoa2109072.
    PubMed     Abstract available


  89. RUBIN EJ, Baden LR, Armstrong KA, Morrissey S, et al
    Audio Interview: The Impact of Covid-19 on Trainees and Junior Faculty.
    N Engl J Med. 2021;385:e21.
    PubMed    


  90. LOPEZ BERNAL J, Andrews N, Gower C, Gallagher E, et al
    Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant.
    N Engl J Med. 2021 Jul 21. doi: 10.1056/NEJMoa2108891.
    PubMed     Abstract available


  91. MADHI SA, Izu A, Pollard AJ
    ChAdOx1 nCoV-19 Vaccine Efficacy against the B.1.351 Variant. Reply.
    N Engl J Med. 2021;385.
    PubMed    


  92. STRUYF F, Sadoff J, Douoguih M
    ChAdOx1 nCoV-19 Vaccine Efficacy against the B.1.351 Variant.
    N Engl J Med. 2021;385.
    PubMed    


  93. EVANS SJW, Jewell NP
    Vaccine Effectiveness Studies in the Field.
    N Engl J Med. 2021 Jul 21. doi: 10.1056/NEJMe2110605.
    PubMed    


  94. RAPEPORT G, Smith E, Gilbert A, Catchpole A, et al
    SARS-CoV-2 Human Challenge Studies - Establishing the Model during an Evolving Pandemic.
    N Engl J Med. 2021 Jul 21. doi: 10.1056/NEJMp2106970.
    PubMed    


  95. MOON S, Alonso Ruiz A, Vieira M
    Averting Future Vaccine Injustice.
    N Engl J Med. 2021;385:193-196.
    PubMed    


  96. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Monoclonal Antibodies and Vaccine Boosts.
    N Engl J Med. 2021;385:e18.
    PubMed    


  97. EICHINGER S, Warkentin TE, Greinacher A
    Thrombotic Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination. Reply.
    N Engl J Med. 2021;385:e11.
    PubMed    


  98. CHOI PY
    Thrombotic Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.
    N Engl J Med. 2021;385:e11.
    PubMed    


  99. LAI KY, Au SY, Fong KM
    Thrombotic Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.
    N Engl J Med. 2021;385:e11.
    PubMed    


  100. NORMARK J, Vikstrom L, Gwon YD, Persson IL, et al
    Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination.
    N Engl J Med. 2021 Jul 14. doi: 10.1056/NEJMc2110716.
    PubMed    


  101. BAROUCH DH, Stephenson KE, Sadoff J, Yu J, et al
    Durable Humoral and Cellular Immune Responses 8 Months after Ad26.COV2.S Vaccination.
    N Engl J Med. 2021 Jul 14. doi: 10.1056/NEJMc2108829.
    PubMed    


  102. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: How Well Are Covid-19 Vaccines Working?
    N Engl J Med. 2021;385:e15.
    PubMed    


  103. BRINKLEY-RUBINSTEIN L, Peterson M, Martin R, Chan P, et al
    Breakthrough SARS-CoV-2 Infections in Prison after Vaccination.
    N Engl J Med. 2021 Jul 7. doi: 10.1056/NEJMc2108479.
    PubMed    


  104. PATRIQUIN CJ, Laroche V, Selby R, Pendergrast J, et al
    Therapeutic Plasma Exchange in Vaccine-Induced Immune Thrombotic Thrombocytopenia.
    N Engl J Med. 2021 Jul 7. doi: 10.1056/NEJMc2109465.
    PubMed    


  105. JARA A, Undurraga EA, Gonzalez C, Paredes F, et al
    Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile.
    N Engl J Med. 2021 Jul 7. doi: 10.1056/NEJMoa2107715.
    PubMed     Abstract available


  106. EDARA VV, Pinsky BA, Suthar MS, Lai L, et al
    Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants.
    N Engl J Med. 2021 Jul 7. doi: 10.1056/NEJMc2107799.
    PubMed    


  107. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Another New Covid-19 Vaccine.
    N Engl J Med. 2021;385:e13.
    PubMed    


  108. ROPPER AH, Klein JP
    Cerebral Venous Thrombosis.
    N Engl J Med. 2021;385:59-64.
    PubMed    


    June 2021
  109. THOMPSON MG, Burgess JL, Naleway AL, Tyner H, et al
    Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.
    N Engl J Med. 2021 Jun 30. doi: 10.1056/NEJMoa2107058.
    PubMed     Abstract available


  110. HEATH PT, Galiza EP, Baxter DN, Boffito M, et al
    Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.
    N Engl J Med. 2021 Jun 30. doi: 10.1056/NEJMoa2107659.
    PubMed     Abstract available


  111. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: A New mRNA Vaccine.
    N Engl J Med. 2021;384:e109.
    PubMed    


  112. HARRIS RJ, Hall JA, Zaidi A, Andrews NJ, et al
    Effect of Vaccination on Household Transmission of SARS-CoV-2 in England.
    N Engl J Med. 2021 Jun 23. doi: 10.1056/NEJMc2107717.
    PubMed    


  113. KAMAR N, Abravanel F, Marion O, Couat C, et al
    Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients.
    N Engl J Med. 2021 Jun 23. doi: 10.1056/NEJMc2108861.
    PubMed    


  114. KRAUSE PR, Fleming TR, Longini IM, Peto R, et al
    SARS-CoV-2 Variants and Vaccines.
    N Engl J Med. 2021 Jun 23. doi: 10.1056/NEJMsr2105280.
    PubMed     Abstract available


  115. KOENIG PA, Schmidt FI
    Spike D614G - A Candidate Vaccine Antigen Against Covid-19.
    N Engl J Med. 2021;384:2349-2351.
    PubMed    


  116. RILEY LE
    mRNA Covid-19 Vaccines in Pregnant Women.
    N Engl J Med. 2021;384:2342-2343.
    PubMed    



  117. SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia.
    N Engl J Med. 2021;384:e92.
    PubMed    


  118. RUBIN EJ, Baden LR, Longo DL, Morrissey S, et al
    Audio Interview: Treating Complications of Covid Vaccination.
    N Engl J Med. 2021;384:e107.
    PubMed    


  119. BOURGUIGNON A, Arnold DM, Warkentin TE, Smith JW, et al
    Adjunct Immune Globulin for Vaccine-Induced Thrombotic Thrombocytopenia.
    N Engl J Med. 2021 Jun 9. doi: 10.1056/NEJMoa2107051.
    PubMed     Abstract available


  120. VANDEBOSCH A, Sadoff J, Douoguih M
    Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19. Reply.
    N Engl J Med. 2021 Jun 9. pii: 10.1056/NEJMc2107809.
    PubMed    


  121. HEININGER U
    Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19.
    N Engl J Med. 2021 Jun 9. pii: 10.1056/NEJMc2107809.
    PubMed    


  122. SAMARAKOON U, Alvarez-Arango S, Blumenthal KG
    Delayed Large Local Reactions to mRNA Covid-19 Vaccines in Blacks, Indigenous Persons, and People of Color.
    N Engl J Med. 2021 Jun 9. doi: 10.1056/NEJMc2108620.
    PubMed    


  123. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Vaccinating Children.
    N Engl J Med. 2021;384:e103.
    PubMed    


  124. TAPIA MD, Sow SO, Naficy A, Diallo F, et al
    Meningococcal Serogroup ACWYX Conjugate Vaccine in Malian Toddlers.
    N Engl J Med. 2021;384:2115-2123.
    PubMed     Abstract available


  125. NEWMAN AM
    Institutional Problems, Individual Solutions - The Burden on Black Physicians.
    N Engl J Med. 2021;384:2076-2078.
    PubMed    


  126. BLACHERE NE, Hacisuleyman E, Darnell RB
    Vaccine Breakthrough Infections with SARS-CoV-2 Variants. Reply.
    N Engl J Med. 2021 Jun 2. pii: 10.1056/NEJMc2107808.
    PubMed    


  127. RANA K, Mohindra R, Pinnaka L
    Vaccine Breakthrough Infections with SARS-CoV-2 Variants.
    N Engl J Med. 2021 Jun 2. pii: 10.1056/NEJMc2107808.
    PubMed    


  128. NIXON DF, Ndhlovu LC
    Vaccine Breakthrough Infections with SARS-CoV-2 Variants.
    N Engl J Med. 2021 Jun 2. pii: 10.1056/NEJMc2107808.
    PubMed    


  129. TAKUVA S, Takalani A, Garrett N, Goga A, et al
    Thromboembolic Events in the South African Ad26.COV2.S Vaccine Study.
    N Engl J Med. 2021 Jun 2. doi: 10.1056/NEJMc2107920.
    PubMed    


    May 2021
  130. FRENCK RW JR, Klein NP, Kitchin N, Gurtman A, et al
    Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents.
    N Engl J Med. 2021 May 27. doi: 10.1056/NEJMoa2107456.
    PubMed     Abstract available


  131. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Protecting the Immunosuppressed against Covid-19.
    N Engl J Med. 2021;384:e88.
    PubMed    


  132. VOLPP KG, Cannuscio CC
    Incentives for Immunity - Strategies for Increasing Covid-19 Vaccine Uptake.
    N Engl J Med. 2021 May 26. doi: 10.1056/NEJMp2107719.
    PubMed    


  133. RUBIN EJ, Baden LR, Drazen JM, Taichman DB, et al
    Audio Interview: Vaccination in Nursing Homes and New Pulmonary/Critical Care Research.
    N Engl J Med. 2021;384:e89.
    PubMed    


  134. VAYNE C, Rollin J, Gruel Y, Pouplard C, et al
    PF4 Immunoassays in Vaccine-Induced Thrombotic Thrombocytopenia.
    N Engl J Med. 2021 May 19. doi: 10.1056/NEJMc2106383.
    PubMed    


  135. WHITE EM, Yang X, Blackman C, Feifer RA, et al
    Incident SARS-CoV-2 Infection among mRNA-Vaccinated and Unvaccinated Nursing Home Residents.
    N Engl J Med. 2021 May 19. doi: 10.1056/NEJMc2104849.
    PubMed    


  136. RUBIN EJ, Baden LR, Gray GE, Morrissey S, et al
    Audio Interview: Vaccination and Variants in the U.S. and South Africa.
    N Engl J Med. 2021;384:e85.
    PubMed    


  137. KEEHNER J, Abeles SR, Torriani FJ
    More on SARS-CoV-2 Infection after Vaccination in Health Care Workers. Reply.
    N Engl J Med. 2021 May 12. pii: 10.1056/NEJMc2106004.
    PubMed    


  138. TOSONI A, Mirijello A, Addolorato G
    More on SARS-CoV-2 Infection after Vaccination in Health Care Workers.
    N Engl J Med. 2021 May 12. pii: 10.1056/NEJMc2106004.
    PubMed    


  139. CHIN ET, Leidner D, Ryckman T, Liu YE, et al
    Covid-19 Vaccine Acceptance in California State Prisons.
    N Engl J Med. 2021 May 12. doi: 10.1056/NEJMc2105282.
    PubMed    


  140. LIU Y, Liu J, Xia H, Zhang X, et al
    BNT162b2-Elicited Neutralization against New SARS-CoV-2 Spike Variants.
    N Engl J Med. 2021 May 12. doi: 10.1056/NEJMc2106083.
    PubMed    


  141. RUBIN EJ, Baden LR, Udwadia ZF, Morrissey S, et al
    Audio Interview: India's Covid-19 Crisis.
    N Engl J Med. 2021;384:e84.
    PubMed    


  142. RATZAN S, Schneider EC, Hatch H, Cacchione J, et al
    Missing the Point - How Primary Care Can Overcome Covid-19 Vaccine "Hesitancy".
    N Engl J Med. 2021 May 5. doi: 10.1056/NEJMp2106137.
    PubMed    


  143. SHINDE V, Bhikha S, Hoosain Z, Archary M, et al
    Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant.
    N Engl J Med. 2021 May 5. doi: 10.1056/NEJMoa2103055.
    PubMed     Abstract available


  144. ABU-RADDAD LJ, Chemaitelly H, Butt AA
    Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants.
    N Engl J Med. 2021 May 5. doi: 10.1056/NEJMc2104974.
    PubMed    


  145. NEUZIL KM
    Interplay between Emerging SARS-CoV-2 Variants and Pandemic Control.
    N Engl J Med. 2021 May 5. doi: 10.1056/NEJMe2103931.
    PubMed    


    April 2021
  146. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Advice for Clinicians on Covid-19 Vaccines and Social Restrictions.
    N Engl J Med. 2021;384:e77.
    PubMed    


  147. GOLDFARB JL, Kreps S, Brownstein JS, Kriner DL, et al
    Beyond the First Dose - Covid-19 Vaccine Follow-through and Continued Protective Measures.
    N Engl J Med. 2021 Apr 28. doi: 10.1056/NEJMp2104527.
    PubMed    


  148. RUBIN EJ, Baden LR, Walensky RP, Morrissey S, et al
    Audio Interview: Covid-19 Vaccines and Pregnancy - A Conversation with CDC Director Rochelle Walensky.
    N Engl J Med. 2021;384:e73.
    PubMed    


  149. BLUMENTHAL KG, Saff RR, Freeman EE
    Delayed Large Local Reactions to mRNA Vaccines. Reply.
    N Engl J Med. 2021 Apr 21. pii: 10.1056/NEJMc2104751.
    PubMed    


  150. BAECK M, Marot L, Belkhir L
    Delayed Large Local Reactions to mRNA Vaccines.
    N Engl J Med. 2021 Apr 21. pii: 10.1056/NEJMc2104751.
    PubMed    


  151. BARDA N, Dagan N, Balicer RD
    BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting. Reply.
    N Engl J Med. 2021;384.
    PubMed    


  152. ROEST S, Hoek RAS, Manintveld OC
    BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting.
    N Engl J Med. 2021;384.
    PubMed    


  153. SADOFF J, Gray G, Vandebosch A, Cardenas V, et al
    Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19.
    N Engl J Med. 2021 Apr 21. doi: 10.1056/NEJMoa2101544.
    PubMed     Abstract available


  154. HACISULEYMAN E, Hale C, Saito Y, Blachere NE, et al
    Vaccine Breakthrough Infections with SARS-CoV-2 Variants.
    N Engl J Med. 2021 Apr 21. doi: 10.1056/NEJMoa2105000.
    PubMed     Abstract available


  155. SHIMABUKURO TT, Kim SY, Myers TR, Moro PL, et al
    Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons.
    N Engl J Med. 2021 Apr 21. doi: 10.1056/NEJMoa2104983.
    PubMed     Abstract available


  156. SCULLY M, Singh D, Lown R, Poles A, et al
    Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination.
    N Engl J Med. 2021 Apr 16. doi: 10.1056/NEJMoa2105385.
    PubMed     Abstract available


  157. CINES DB, Bussel JB
    SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia.
    N Engl J Med. 2021 Apr 16. doi: 10.1056/NEJMe2106315.
    PubMed    


  158. SADOFF J, Davis K, Douoguih M
    Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination - Response from the Manufacturer.
    N Engl J Med. 2021 Apr 16. doi: 10.1056/NEJMc2106075.
    PubMed    


  159. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Vaccine Successes and Vaccine Adverse Events.
    N Engl J Med. 2021;384:e70.
    PubMed    


  160. ROSENBAUM L
    No Cure without Care - Soothing Science Skepticism.
    N Engl J Med. 2021;384:1462-1465.
    PubMed    


  161. LIU Y, Liu J, Xia H, Zhang X, et al
    Neutralizing Activity of BNT162b2-Elicited Serum.
    N Engl J Med. 2021;384:1466-1468.
    PubMed    


  162. MUIR KL, Kallam A, Koepsell SA, Gundabolu K, et al
    Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination.
    N Engl J Med. 2021 Apr 14. doi: 10.1056/NEJMc2105869.
    PubMed    


  163. ANICHINI G, Terrosi C, Gandolfo C, Gori Savellini G, et al
    SARS-CoV-2 Antibody Response in Persons with Past Natural Infection.
    N Engl J Med. 2021 Apr 14. doi: 10.1056/NEJMc2103825.
    PubMed    


  164. GREINACHER A, Thiele T, Warkentin TE, Weisser K, et al
    Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination.
    N Engl J Med. 2021 Apr 9. doi: 10.1056/NEJMoa2104840.
    PubMed     Abstract available


  165. SCHULTZ NH, Sorvoll IH, Michelsen AE, Munthe LA, et al
    Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.
    N Engl J Med. 2021 Apr 9. doi: 10.1056/NEJMoa2104882.
    PubMed     Abstract available


  166. KATZ IT, Weintraub R, Bekker LG, Brandt AM, et al
    From Vaccine Nationalism to Vaccine Equity - Finding a Path Forward.
    N Engl J Med. 2021;384:1281-1283.
    PubMed    


  167. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Antibody Responses to Natural Infection and Vaccination.
    N Engl J Med. 2021;384:e65.
    PubMed    


  168. MOYO-GWETE T, Madzivhandila M, Makhado Z, Ayres F, et al
    Cross-Reactive Neutralizing Antibody Responses Elicited by SARS-CoV-2 501Y.V2 (B.1.351).
    N Engl J Med. 2021 Apr 7. doi: 10.1056/NEJMc2104192.
    PubMed    


  169. LUSTIG Y, Nemet I, Kliker L, Zuckerman N, et al
    Neutralizing Response against Variants after SARS-CoV-2 Infection and One Dose of BNT162b2.
    N Engl J Med. 2021 Apr 7. doi: 10.1056/NEJMc2104036.
    PubMed    


  170. SHEN X, Tang H, Pajon R, Smith G, et al
    Neutralization of SARS-CoV-2 Variants B.1.429 and B.1.351.
    N Engl J Med. 2021 Apr 7. doi: 10.1056/NEJMc2103740.
    PubMed    


  171. DORIA-ROSE N, Suthar MS, Makowski M, O'Connell S, et al
    Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19.
    N Engl J Med. 2021 Apr 6. doi: 10.1056/NEJMc2103916.
    PubMed    


  172. WANG GL, Wang ZY, Duan LJ, Meng QC, et al
    Susceptibility of Circulating SARS-CoV-2 Variants to Neutralization.
    N Engl J Med. 2021 Apr 6. doi: 10.1056/NEJMc2103022.
    PubMed    


  173. RUBIN EJ, Baden LR, Del Rio C, Akusobi C, et al
    Audio Interview: Delivering Covid-19 Vaccines to Minority Communities.
    N Engl J Med. 2021;384:e60.
    PubMed    


  174. MBALA-KINGEBENI P, Pratt C, Mutafali-Ruffin M, Pauthner MG, et al
    Ebola Virus Transmission Initiated by Relapse of Systemic Ebola Virus Disease.
    N Engl J Med. 2021;384:1240-1247.
    PubMed     Abstract available


    March 2021
  175. QUINN SC, Andrasik MP
    Addressing Vaccine Hesitancy in BIPOC Communities - Toward Trustworthiness, Partnership, and Reciprocity.
    N Engl J Med. 2021 Mar 31. doi: 10.1056/NEJMp2103104.
    PubMed    


  176. HALL MA, Studdert DM
    "Vaccine Passport" Certification - Policy and Ethical Considerations.
    N Engl J Med. 2021 Mar 31. doi: 10.1056/NEJMp2104289.
    PubMed    


  177. NACHEGA JB, Sam-Agudu NA, Mellors JW, Zumla A, et al
    Scaling Up Covid-19 Vaccination in Africa - Lessons from the HIV Pandemic.
    N Engl J Med. 2021 Mar 31. doi: 10.1056/NEJMp2103313.
    PubMed    


  178. DESMOND A, Offit PA
    On the Shoulders of Giants - From Jenner's Cowpox to mRNA Covid Vaccines.
    N Engl J Med. 2021;384:1081-1083.
    PubMed    


  179. FEINBERG MB
    Uhambo - Twists and Turns on the Journey to an Efficacious HIV-1 Vaccine.
    N Engl J Med. 2021;384:1157-1159.
    PubMed    


  180. GRAY GE, Bekker LG, Laher F, Malahleha M, et al
    Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120-MF59 in Adults.
    N Engl J Med. 2021;384:1089-1100.
    PubMed     Abstract available


  181. RUBIN EJ, Baden LR, Brandt AM, Morrissey S, et al
    Audio Interview: What Earlier Epidemics Teach Us about Covid-19.
    N Engl J Med. 2021;384:e55.
    PubMed    


  182. ABDOOL KARIM SS, de Oliveira T
    New SARS-CoV-2 Variants - Clinical, Public Health, and Vaccine Implications.
    N Engl J Med. 2021 Mar 24. doi: 10.1056/NEJMc2100362.
    PubMed    


  183. KEEHNER J, Horton LE, Pfeffer MA, Longhurst CA, et al
    SARS-CoV-2 Infection after Vaccination in Health Care Workers in California.
    N Engl J Med. 2021 Mar 23. doi: 10.1056/NEJMc2101927.
    PubMed    


  184. BRADLEY T, Grundberg E, Selvarangan R, LeMaster C, et al
    Antibody Responses after a Single Dose of SARS-CoV-2 mRNA Vaccine.
    N Engl J Med. 2021 Mar 23. doi: 10.1056/NEJMc2102051.
    PubMed    


  185. DANIEL W, Nivet M, Warner J, Podolsky DK, et al
    Early Evidence of the Effect of SARS-CoV-2 Vaccine at One Medical Center.
    N Engl J Med. 2021 Mar 23. doi: 10.1056/NEJMc2102153.
    PubMed    


  186. BENENSON S, Oster Y, Cohen MJ, Nir-Paz R, et al
    BNT162b2 mRNA Covid-19 Vaccine Effectiveness among Health Care Workers.
    N Engl J Med. 2021 Mar 23. doi: 10.1056/NEJMc2101951.
    PubMed    


  187. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Efficacy of Current Covid-19 Vaccines against Variant Viruses.
    N Engl J Med. 2021;384:e53.
    PubMed    


  188. WU K, Werner AP, Koch M, Choi A, et al
    Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine.
    N Engl J Med. 2021 Mar 17. doi: 10.1056/NEJMc2102179.
    PubMed    


  189. MADHI SA, Baillie V, Cutland CL, Voysey M, et al
    Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant.
    N Engl J Med. 2021 Mar 16. doi: 10.1056/NEJMoa2102214.
    PubMed     Abstract available


  190. RUBIN EJ, Baden LR, Abraham J, Morrissey S, et al
    Audio Interview: The Implications of Changes in the Structural Biology of SARS-CoV-2.
    N Engl J Med. 2021;384:e48.
    PubMed    


  191. KRAMMER F, Srivastava K, Alshammary H, Amoako AA, et al
    Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine.
    N Engl J Med. 2021 Mar 10. doi: 10.1056/NEJMc2101667.
    PubMed    


  192. GORALNICK E, Kaufmann C, Gawande AA
    Mass-Vaccination Sites - An Essential Innovation to Curb the Covid-19 Pandemic.
    N Engl J Med. 2021 Mar 10. doi: 10.1056/NEJMp2102535.
    PubMed    


  193. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: A New SARS-CoV-2 Vaccine and a New Look at Treatment.
    N Engl J Med. 2021;384:e46.
    PubMed    


  194. BLUMENTHAL KG, Freeman EE, Saff RR, Robinson LB, et al
    Delayed Large Local Reactions to mRNA-1273 Vaccine against SARS-CoV-2.
    N Engl J Med. 2021 Mar 3. doi: 10.1056/NEJMc2102131.
    PubMed    


  195. STEELFISHER GK, Blendon RJ, Caporello H
    An Uncertain Public - Encouraging Acceptance of Covid-19 Vaccines.
    N Engl J Med. 2021 Mar 3. doi: 10.1056/NEJMp2100351.
    PubMed    


  196. BARSKY BA, Reinhart E, Farmer P, Keshavjee S, et al
    Vaccination plus Decarceration - Stopping Covid-19 in Jails and Prisons.
    N Engl J Med. 2021 Mar 3. doi: 10.1056/NEJMp2100609.
    PubMed    


  197. KRAMER DB, Opel DJ, Parasidis E, Mello MM, et al
    Choices in a Crisis - Individual Preferences among SARS-CoV-2 Vaccines.
    N Engl J Med. 2021 Mar 3. doi: 10.1056/NEJMp2102146.
    PubMed    


    February 2021
  198. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: The Real-World Effectiveness of Covid-19 Vaccination.
    N Engl J Med. 2021;384:e40.
    PubMed    


  199. DAGAN N, Barda N, Kepten E, Miron O, et al
    BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting.
    N Engl J Med. 2021 Feb 24. doi: 10.1056/NEJMoa2101765.
    PubMed     Abstract available


  200. UBEL PA
    Vaccinating Health Care Employees - Do They All Deserve Early Access?
    N Engl J Med. 2021 Feb 19. doi: 10.1056/NEJMpv2101203.
    PubMed    


  201. RUBIN EJ, Baden LR, Farrar JJ, Morrissey S, et al
    Audio Interview: Viral Variants and Covid-19.
    N Engl J Med. 2021;384:e38.
    PubMed    


  202. ABSALON J, Koury K, Gruber WC
    Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. Reply.
    N Engl J Med. 2021;384.
    PubMed    


  203. WANG X
    Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
    N Engl J Med. 2021;384.
    PubMed    


  204. VERGNES JN
    Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
    N Engl J Med. 2021;384.
    PubMed    


  205. SKOWRONSKI DM, De Serres G
    Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
    N Engl J Med. 2021;384.
    PubMed    


  206. KADIRE SR, Wachter RM, Lurie N
    Delayed Second Dose versus Standard Regimen for Covid-19 Vaccination.
    N Engl J Med. 2021 Feb 17. doi: 10.1056/NEJMclde2101987.
    PubMed    


  207. WU K, Werner AP, Koch M, Choi A, et al
    Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine - Preliminary Report.
    N Engl J Med. 2021 Feb 17. doi: 10.1056/NEJMc2102179.
    PubMed    


  208. ROSENBAUM L
    Escaping Catch-22 - Overcoming Covid Vaccine Hesitancy.
    N Engl J Med. 2021 Feb 12. doi: 10.1056/NEJMms2101220.
    PubMed    


  209. HALLEY MC, Mangurian C
    Caring for the Caregivers - Covid-19 Vaccination for Essential Members of the Health Care Team.
    N Engl J Med. 2021 Feb 12. doi: 10.1056/NEJMpv2101339.
    PubMed    


  210. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Does Vaccination Mean the End of Masking and Social Distancing?
    N Engl J Med. 2021;384:e32.
    PubMed    


  211. PAGE K, Melia MT, Veenhuis RT, Winter M, et al
    Randomized Trial of a Vaccine Regimen to Prevent Chronic HCV Infection.
    N Engl J Med. 2021;384:541-549.
    PubMed     Abstract available


  212. CASTELLS MC, Phillips EJ
    Maintaining Safety with SARS-CoV-2 Vaccines. Reply.
    N Engl J Med. 2021 Feb 10. pii: 10.1056/NEJMc2100766.
    PubMed    


  213. ROLLA G, Brussino L, Badiu I
    Maintaining Safety with SARS-CoV-2 Vaccines.
    N Engl J Med. 2021 Feb 10. pii: 10.1056/NEJMc2100766.
    PubMed    


  214. GERBERDING JL, Haynes BF
    Vaccine Innovations - Past and Future.
    N Engl J Med. 2021;384:393-396.
    PubMed    


  215. RUBIN EJ, Baden LR, Northam RS, Morrissey S, et al
    Audio Interview: Covid-19 and the States - A Conversation with Ralph Northam.
    N Engl J Med. 2021;384:e25.
    PubMed    


    January 2021
  216. RUBIN EJ, Baden LR, Fauci AS, Morrissey S, et al
    Audio Interview: A Covid-19 Conversation with Anthony Fauci.
    N Engl J Med. 2021;384:e22.
    PubMed    


  217. LEE TH, Chen AH
    Last-Mile Logistics of Covid Vaccination - The Role of Health Care Organizations.
    N Engl J Med. 2021 Jan 27. doi: 10.1056/NEJMp2100574.
    PubMed    


  218. HEATON PM
    The Covid-19 Vaccine-Development Multiverse. Reply.
    N Engl J Med. 2021;384.
    PubMed    


  219. KOJIMA N, Turner I, Klausner JD
    The Covid-19 Vaccine-Development Multiverse.
    N Engl J Med. 2021;384.
    PubMed    


  220. RUBIN EJ, Baden LR, Nottage K, O'Connell J, et al
    Audio Interview: An International Look at Covid-19.
    N Engl J Med. 2021;384:e19.
    PubMed    


  221. KLASS P, Ratner AJ
    Vaccinating Children against Covid-19 - The Lessons of Measles.
    N Engl J Med. 2021 Jan 20. doi: 10.1056/NEJMp2034765.
    PubMed    


  222. VAN TASSEL K, Shachar C, Hoffman S
    Covid-19 Vaccine Injuries - Preventing Inequities in Compensation.
    N Engl J Med. 2021 Jan 20. doi: 10.1056/NEJMp2034438.
    PubMed    


  223. HUGHES MT, Kahn J, Kachalia A
    Who Goes First? Government Leaders and Prioritization of SARS-CoV-2 Vaccines.
    N Engl J Med. 2021 Jan 20. doi: 10.1056/NEJMpv2036128.
    PubMed    


  224. BAJAJ SS, Stanford FC
    Beyond Tuskegee - Vaccine Distrust and Everyday Racism.
    N Engl J Med. 2021 Jan 20. doi: 10.1056/NEJMpv2035827.
    PubMed    


  225. RUBIN EJ, Baden LR, Abdool Karim SS, Morrissey S, et al
    Audio Interview: Covid-19 in South Africa and a New SARS-CoV-2 Variant.
    N Engl J Med. 2021;384:e14.
    PubMed    


  226. SADOFF J, Le Gars M, Shukarev G, Heerwegh D, et al
    Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine.
    N Engl J Med. 2021 Jan 13. doi: 10.1056/NEJMoa2034201.
    PubMed     Abstract available


  227. RUBIN EJ, Baden LR, Lee TH, Morrissey S, et al
    Audio Interview: Planning for the SARS-CoV-2 Vaccine Rollout.
    N Engl J Med. 2021;384:e13.
    PubMed    


  228. WOOD S, Schulman K
    Beyond Politics - Promoting Covid-19 Vaccination in the United States.
    N Engl J Med. 2021 Jan 6. doi: 10.1056/NEJMms2033790.
    PubMed    


    December 2020
  229. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: A Look at Covid-19 Prevention and Care in 2020.
    N Engl J Med. 2020;383:e147.
    PubMed    


  230. BADEN LR, El Sahly HM, Essink B, Kotloff K, et al
    Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
    N Engl J Med. 2020 Dec 30. doi: 10.1056/NEJMoa2035389.
    PubMed     Abstract available


  231. HAYNES BF
    A New Vaccine to Battle Covid-19.
    N Engl J Med. 2020 Dec 30. doi: 10.1056/NEJMe2035557.
    PubMed    


  232. FOPPIANO PALACIOS C, Travassos MA
    Vaccinating Detained Migrants against SARS-CoV-2 - Preventing Another Tragedy.
    N Engl J Med. 2020 Dec 30. doi: 10.1056/NEJMpv2035416.
    PubMed    


  233. CASTELLS MC, Phillips EJ
    Maintaining Safety with SARS-CoV-2 Vaccines.
    N Engl J Med. 2020 Dec 30. doi: 10.1056/NEJMra2035343.
    PubMed    


  234. BAROCAS JA
    Business Not as Usual - Covid-19 Vaccination in Persons with Substance Use Disorders.
    N Engl J Med. 2020 Dec 30. doi: 10.1056/NEJMpv2035709.
    PubMed    


  235. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Covid-19 Vaccine Fundamentals.
    N Engl J Med. 2020;383:e146.
    PubMed    


  236. POLACK FP, Thomas SJ, Kitchin N, Absalon J, et al
    Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
    N Engl J Med. 2020 Dec 10. doi: 10.1056/NEJMoa2034577.
    PubMed     Abstract available


  237. RUBIN EJ, Longo DL
    SARS-CoV-2 Vaccination - An Ounce (Actually, Much Less) of Prevention.
    N Engl J Med. 2020 Dec 10. doi: 10.1056/NEJMe2034717.
    PubMed    


  238. RUBIN EJ, Baden LR, Barocas JA, Morrissey S, et al
    Audio Interview: SARS-CoV-2 Vaccination and Vulnerable Populations.
    N Engl J Med. 2020;383:e143.
    PubMed    


  239. WIDGE AT, Rouphael NG, Jackson LA, Anderson EJ, et al
    Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination.
    N Engl J Med. 2020 Dec 3. doi: 10.1056/NEJMc2032195.
    PubMed    


  240. KRAUSE PR, Fleming TR, Longini IM, Peto R, et al
    Placebo-Controlled Trials of Covid-19 Vaccines - Why We Still Need Them.
    N Engl J Med. 2020 Dec 2. doi: 10.1056/NEJMp2033538.
    PubMed    


    November 2020
  241. RUBIN EJ, Baden LR, Haug CJ, Morrissey S, et al
    Audio Interview: Covid-19 in Europe and New Information on Vaccines.
    N Engl J Med. 2020;383:e134.
    PubMed    


  242. REDDY SN, Nair NP, Tate JE, Thiyagarajan V, et al
    Intussusception after Rotavirus Vaccine Introduction in India.
    N Engl J Med. 2020;383:1932-1940.
    PubMed     Abstract available


  243. RUBIN EJ, Baden LR, Woodcock J, Morrissey S, et al
    Audio Interview: An Update from Operation Warp Speed.
    N Engl J Med. 2020;383:e127.
    PubMed    


  244. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: What the U.S. Response to Covid-19 Looks Like Today.
    N Engl J Med. 2020;383:e123.
    PubMed    


    October 2020
  245. HALABI S, Heinrich A, Omer SB
    No-Fault Compensation for Vaccine Injury - The Other Side of Equitable Access to Covid-19 Vaccines.
    N Engl J Med. 2020 Oct 28. doi: 10.1056/NEJMp2030600.
    PubMed    


  246. STRASSLE C, Jardas E, Ochoa J, Berkman BE, et al
    Covid-19 Vaccine Trials and Incarcerated People - The Ethics of Inclusion.
    N Engl J Med. 2020 Oct 21. doi: 10.1056/NEJMp2025955.
    PubMed    


  247. KRAUSE PR, Gruber MF
    Emergency Use Authorization of Covid Vaccines - Safety and Efficacy Follow-up Considerations.
    N Engl J Med. 2020 Oct 16. doi: 10.1056/NEJMp2031373.
    PubMed    


  248. WARREN RC, Forrow L, Hodge DA Sr, Truog RD, et al
    Trustworthiness before Trust - Covid-19 Vaccine Trials and the Black Community.
    N Engl J Med. 2020 Oct 16. doi: 10.1056/NEJMp2030033.
    PubMed    


  249. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Vaccinology and Covid-19.
    N Engl J Med. 2020;383:e109.
    PubMed    


  250. WALSH EE, Frenck RW Jr, Falsey AR, Kitchin N, et al
    Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates.
    N Engl J Med. 2020 Oct 14. doi: 10.1056/NEJMoa2027906.
    PubMed     Abstract available


  251. LEI J, Ploner A, Elfstrom KM, Wang J, et al
    HPV Vaccination and the Risk of Invasive Cervical Cancer.
    N Engl J Med. 2020;383:1340-1348.
    PubMed     Abstract available


    September 2020
  252. ANDERSON EJ, Rouphael NG, Widge AT, Jackson LA, et al
    Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults.
    N Engl J Med. 2020 Sep 29. doi: 10.1056/NEJMoa2028436.
    PubMed     Abstract available


  253. CHRISTIE A, Neatherlin JC, Nichol ST, Beach M, et al
    Ebola Response Priorities in the Time of Covid-19.
    N Engl J Med. 2020;383:1202-1204.
    PubMed    


  254. SCHWARTZ JL
    Evaluating and Deploying Covid-19 Vaccines - The Importance of Transparency, Scientific Integrity, and Public Trust.
    N Engl J Med. 2020 Sep 23. doi: 10.1056/NEJMp2026393.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: